• LAST PRICE
    17.8200
  • TODAY'S CHANGE (%)
    Trending Up0.1800 (1.0204%)
  • Bid / Lots
    18.1500/ 2
  • Ask / Lots
    18.3000/ 29
  • Open / Previous Close
    17.6400 / 17.6400
  • Day Range
    Low 17.4700
    High 18.0100
  • 52 Week Range
    Low 4.2300
    High 61.9000
  • Volume
    89,853
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 17.64
TimeVolumeCRBP
09:32 ET66917.64
09:33 ET11317.6744
09:35 ET30017.92
09:42 ET30017.805
09:44 ET20017.765
09:46 ET47617.7
09:48 ET50017.72
09:53 ET11117.64
09:57 ET28217.655
10:00 ET90617.4963
10:02 ET10017.5325
10:04 ET30017.66
10:06 ET10017.64
10:09 ET10017.73
10:11 ET70017.74
10:13 ET60717.8
10:15 ET70817.87
10:18 ET21917.76
10:20 ET36117.7001
10:22 ET10017.755
10:24 ET20017.7
10:26 ET10017.77
10:27 ET10017.82
10:33 ET24717.78
10:36 ET10017.84
10:38 ET10017.815
10:42 ET85617.7108
10:44 ET287717.765
10:49 ET50817.8
10:51 ET20017.84
10:56 ET10017.81
10:58 ET288717.92
11:00 ET48017.94
11:05 ET10017.86
11:07 ET30017.9
11:14 ET10017.82
11:18 ET30017.76
11:25 ET30017.89
11:34 ET30017.88
11:36 ET20017.76
11:39 ET10017.84
11:41 ET15517.81
11:43 ET10017.84
11:48 ET10017.825
11:50 ET30017.9
11:52 ET258917.95
11:56 ET25517.9089
11:59 ET45217.895
12:03 ET24017.87
12:06 ET25017.865
12:10 ET10017.915
12:14 ET40017.9
12:15 ET70017.92
12:19 ET20017.84
12:28 ET10017.88
12:35 ET30017.92
12:44 ET50017.95
12:46 ET52018.01
12:50 ET30017.975
12:51 ET60017.89
12:53 ET57317.91
12:55 ET81317.885
12:57 ET409317.865
01:00 ET2993817.82
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRBP
Corbus Pharmaceuticals Holdings Inc
214.8M
-3.8x
---
United StatesCMPX
Compass Therapeutics Inc.
214.6M
-4.6x
---
United StatesHURA
TuHURA Biosciences Inc
213.5M
-0.5x
---
United StatesCLYM
Climb Bio Inc
216.5M
-1.5x
---
United StatesTRVI
Trevi Therapeutics Inc
216.8M
-6.5x
---
United StatesKYTX
Kyverna Therapeutics Inc
218.4M
-2.3x
---
As of 2024-11-29

Company Information

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.

Contact Information

Headquarters
500 River Ridge DriveNORWOOD, MA, United States 02062
Phone
617-963-0103
Fax
---

Executives

Independent Chairman of the Board
Alan Holmer
Chief Executive Officer, Director
Yuval Cohen
Chief Financial Officer
Sean Moran
Chief Medical Officer
Dominic Smethurst
Independent Director
Anne Altmeyer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$214.8M
Revenue (TTM)
$0.00
Shares Outstanding
12.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.58
EPS
$-4.69
Book Value
$-1.56
P/E Ratio
-3.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.